Pharming Group appoints new head of finance
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 02 2025
0mins
Should l Buy ?
Source: SeekingAlpha
CFO Appointment: Pharming Group has appointed Kenneth Lynard as CFO, effective October 1, 2025, bringing over 20 years of experience in the life sciences industry.
Company Updates: Pharming Group recently reported its Q2 2025 results and is mentioned alongside KalVista Pharmaceuticals, which saw a rise in stock after receiving FDA approval for Ekterly.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
